北美医药溶剂市场 – 行业趋势及 2028 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

北美医药溶剂市场 – 行业趋势及 2028 年预测

  • Chemical and Materials
  • Published Report
  • Nov 2021
  • North America
  • 350 页面
  • 桌子數: 119
  • 图号: 28

北美制药溶剂市场,按产品(酒精、胺、酯、醚、芳香烃、氯化溶剂、酮等)、应用(制药、研究实验室、化学等)、国家(美国、加拿大和墨西哥)划分的市场趋势和预测到 2028 年。

北美医药溶剂市场市场分析与洞察:北美医药溶剂市场

预计北美医药溶剂市场将在 2021 年至 2028 年的预测期内获得显着增长。Data Bridge Market Research 分析称,在 2021 年至 2028 年的预测期内,该市场的复合年增长率为 4.6%,预计到 2028 年将达到 2,271,558.55 万美元。  

制药溶剂是指主要用于制药行业药品制造的化学化合物。这些溶剂用于溶解其他产品和成分,通过提供生产药物和药品所需的分子,将其用作制造块。这些溶剂还用于提取和纯化过程。大多数制药溶剂无法从最终药物中完全去除。然而,人们希望制药溶剂不应改变参与反应的任何一种化学物质的性质。

这些醇类溶剂用于多种主要药物,如乙二醇、异丙醇和乙醇,制药和医疗保健行业的增长是推动市场增长的主要因素。此外,高生产成本和复杂的制造工艺也制约了市场的增长。另一方面,不断增长的研发活动和新药制造方法和技术的开发为市场带来了机遇。然而,对溶剂毒性的担忧加剧可能会进一步给市场增长带来挑战。

北美制药溶剂市场报告提供了市场份额、新发展和产品线分析的详细信息,国内和本地市场参与者的影响,分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和全球制药溶剂市场情景,请联系 Data Bridge Market Research 获取分析师简报;我们的团队将帮助您创建收入影响解决方案,以实现您的预​​期目标。

北美医药溶剂市场北美医药溶剂市场范围和市场规模

北美医药溶剂市场根据产品和应用分为两个显著的​​细分市场。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略,并确定您的核心应用领域和目标市场的差异。

  • 根据产品,北美药用溶剂市场细分为酒精、胺、酯、醚、芳香烃、氯化溶剂、酮等。预计 2021 年酒精将主导北美药用溶剂市场,因为酒精溶剂可以溶解药物而不改变其成分,并且还具有多种浓度依赖性的药理作用,包括镇静、驱风、降温、解热、发红、清洁和防腐作用。
  • 根据应用,北美医药溶剂市场分为制药、研究实验室、化学和其他。2021 年,制药部门预计将占据市场主导地位,因为酒精溶剂在该地区广泛用作外用消毒剂和消毒剂。

医药溶剂市场国家层面分析

分析了北美市场,并按产品和应用提供了市场规模信息。北美医药溶剂市场报告涵盖的国家包括美国、加拿大和墨西哥。由于该地区的医药和医疗保健行业不断发展,北美在市场上占据主导地位。

医药溶剂市场(按应用)

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外,在提供国家数据的预测分析时,还考虑了北美品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。

医学研发的增长推动了北美医药溶剂市场的增长

北美医药溶剂市场还为您提供每个国家/地区不同类型产品安装基数增长的详细市场分析、使用生命线曲线的技术影响以及婴儿配方奶粉监管情景的变化及其对市场的影响。数据涵盖 2011 年至 2019 年的历史时期。

竞争格局和医药溶剂市场份额分析

北美医药溶剂市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、公司优势和劣势、产品发布、临床试验渠道、品牌分析、产品批准、专利、产品宽度和广度、应用主导地位和技术生命线曲线。以上提供的数据点仅与公司对北美医药溶剂市场的关注有关。

全球医药溶剂市场的主要参与者包括杜邦、三井化学、陶氏、Brenntag SE、默克集团、荷兰皇家壳牌公司、巴斯夫 SE、埃克森美孚公司、科莱恩、伊士曼化学公司、利安德巴塞尔工业控股公司、Olin Corporation、SK geo centric Co., Ltd.、Avantor, Inc. 等

例如,

  • 2021年7月,杜邦公司完成对高性能电磁屏蔽和热管理解决方案全球领导者莱尔德性能材料公司的收购。此举将帮助公司扩大客户群和全球规模,加快进入市场的速度。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 PRODUCT LIFE LINE CURVE

2.7 MULTIVARIATE MODELLING

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 MARKET APPLICATION COVERAGE GRID

2.12 DBMR MARKET CHALLENGE MATRIX

2.13 SECONDARY SOURCES

2.14 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 RAW MATERIAL OUTLOOK

4.2 ADOPTION SCENARIO AMONG BUYERS

4.3 VALUE CHAIN ANALYSIS

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 GROWTH IN PHARMACEUTICAL, AND HEALTHCARE SECTOR ACROSS THE GLOBE

5.1.2 RISE IN PRODUCTION OF INNOVATIVE GENERIC DRUGS, PARTICULARLY IN EMERGING ECONOMIES

5.1.3 INCREASE IN DEMAND FOR ALCOHOL SOLVENTS FOR MANUFACTURING OF VARIOUS DRUGS

5.2 RESTRAINTS

5.2.1 HIGH PRODUCTION COSTS, AND COMPLEX MANUFACTURING PROCESS

5.2.2 STRINGENT REGULATIONS REGARDING THE USE OF CERTAIN CONVENTIONAL SOLVENTS

5.3 OPPORTUNITIES

5.3.1 GROWTH IN RESEARCH AND DEVELOPMENT ACTIVITIES

5.3.2 DEVELOPMENT OF NEW DRUG MANUFACTURING METHODS AND TECHNOLOGIES

5.3.3 RISE IN ADOPTION OF GREEN MATERIALS AND CHEMICALS FOR DRUG MANUFACTURING

5.4 CHALLENGES

5.4.1 RISE IN CONCERNS REGARDING THE TOXICITY OF SOLVENTS

5.4.2 OCCURRENCES OF FATALITIES IN THE PHARMACEUTICAL SOLVENT MANUFACTURING COMPANIES

6 ANALYSIS ON IMPACT OF COVID-19 ON THE MARKET

6.1 AFTERMATH OF COVID-19 AND THE GOVERNMENT INITIATIVE TO BOOST THE MARKET

6.2 STRATEGIC DECISIONS OF MANUFACTURERS AFTER COVID-19 TO GET COMPETITIVE MARKET SHARE

6.3 IMPACT ON PRICE

6.4 IMPACT ON DEMAND

6.5 IMPACT ON SUPPLY CHAIN

6.6 CONCLUSION

7 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT

7.1 OVERVIEW

7.2 ALCOHOL

7.2.1 METHANOL

7.2.2 ETHANOL

7.2.3 1-BUTANOL

7.2.4 2-BUTANOL

7.2.5 2-METHOXYETHANOL

7.2.6 3-METHYL-1-PROPANOL

7.2.7 2-METHYL-1-PROPANOL

7.2.8 1-PENTANOL

7.2.9 1-PROPANOL

7.2.10 2-PROPANOL (ISOPROPYL ALCOHOL)

7.2.11 OTHERS

7.3 AROMATIC HYDROCARBONS

7.3.1 TOLUENE

7.3.2 XYLENE

7.3.3 ETHYLBENZENE

7.3.4 OTHERS

7.4 KETONES

7.4.1 ACETONE

7.4.2 CYCLOHEXANONE

7.4.3 METHYL ETHER KETONE

7.4.4 METHYL ETHYL KETONE

7.4.5 METHYL ISOBUTYL KETONE

7.4.6 OTHERS

7.5 ETHERS

7.5.1 DIETHYL ETHER

7.5.2 METHOXYETHANE

7.5.3 TETRAHYDROFURAN

7.5.4 METHYL TERT-BUTYL ETHER

7.5.5 DI-N-PROPYL ETHER

7.5.6 OTHERS

7.6 AMINE

7.6.1 MONOETHANOLAMINE (MEA)

7.6.2 DIETHANOLAMINE (DEA)

7.6.3 METHYLDIETHANOLAMINE (MDEA)

7.6.4 OTHERS

7.7 ESTERS

7.7.1 ACETYL ACETATE

7.7.2 ETHYL ACETATE

7.7.3 BUTYL ACETATE

7.7.4 OTHERS

7.8 CHLORINATED SOLVENTS

7.8.1 TRICHLOROETHYLENE (TCE)

7.8.2 PERCHLOROETHYLENE (PCE)

7.8.3 1,1,1-TRICHLOROETHANE (TCA)

7.8.4 OTHERS

7.9 OTHERS

8 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 PHARMACEUTICAL

8.3 RESEARCH LABORATORIES

8.4 CHEMICAL

8.5 OTHERS

9 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET

9.1 NORTH AMERICA

9.1.1 U.S.

9.1.2 CANADA

9.1.3 MEXICO

10 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: COMPANY LANDSCAPE

10.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

10.2 MERGERS & ACQUISITIONS

10.3 EXPANSION

10.4 NEW PRODUCT DEVELOPMENT

10.5 PARTNERSHIP

10.6 AGREEMENTS

10.7 AWARD AND CERTIFICATION

11 SWOT ANALYSIS

12 COMPANY PROFILE

12.1 ROYAL DUTCH SHELL PLC

12.1.1 COMPANY SNAPSHOT

12.1.2 REVENUS ANALYSIS

12.1.3 COMPANY SHARE ANALYSIS

12.1.4 PRODUCT PORTFOLIO

12.1.5 RECENT DEVELOPMENT

12.2 BASF SE

12.2.1 COMPANY SNAPSHOT

12.2.2 REVENUS ANALYSIS

12.2.3 COMPANY SHARE ANALYSIS

12.2.4 PRODUCT PORTFOLIO

12.2.5 RECENT DEVELOPMENT

12.3 MERCK KGAA

12.3.1 COMPANY SNAPSHOT

12.3.2 REVENUE ANALYSIS

12.3.3 COMPANY SHARE ANALYSIS

12.3.4 PRODUCT PORTFOLIO

12.3.5 RECENT DEVELOPMENT

12.4 EXXON MOBIL CORPORATION

12.4.1 COMPANY SNAPSHOT

12.4.2 REVENUE ANALYSIS

12.4.3 COMPANY SHARE ANALYSIS

12.4.4 PRODUCT PORTFOLIO

12.4.5 RECENT DEVELOPMENT

12.5 BRENNTAG SE

12.5.1 COMPANY SNAPSHOT

12.5.2 REVENUE ANALYSIS

12.5.3 COMPANY SHARE ANALYSIS

12.5.4 PRODUCT PORTFOLIO

12.5.5 RECENT DEVELOPMENT

12.6 DUPONT

12.6.1 COMPANY SNAPSHOT

12.6.2 REVENUS ANALYSIS

12.6.3 PRODUCT PORTFOLIO

12.6.4 RECENT DEVELOPMENTS

12.7 MITSUI CHEMICALS

12.7.1 COMPANY SNAPSHOT

12.7.2 REVENUE ANALYSIS

12.7.3 PRODUCT PORTFOLIO

12.7.4 RECENT DEVELOPMENT

12.8 DOW

12.8.1 COMPANY SNAPSHOT

12.8.2 REVENUS ANALYSIS

12.8.3 PRODUCT PORTFOLIO

12.8.4 RECENT DEVELOPMENT

12.9 LYONDELLBASELL INDUSTRIES HOLDINGS B.V.

12.9.1 COMPANY SNAPSHOT

12.9.2 REVENUS ANALYSIS

12.9.3 PRODUCT PORTFOLIO

12.9.4 RECENT DEVELOPMENT

12.1 CLARIANT AG

12.10.1 COMPANY SNAPSHOT

12.10.2 REVENUE ANALYSIS

12.10.3 PRODUCT PORTFOLIO

12.10.4 RECENT DEVELOPMENT

12.11 AVANTOR, INC.

12.11.1 COMPANY SNAPSHOT

12.11.2 REVENUE ANALYSIS

12.11.3 PRODUCT PORTFOLIO

12.11.4 RECENT DEVELOPMENT

12.12 EASTMAN CHEMICAL COMPANY

12.12.1 COMPANY SNAPSHOT

12.12.2 REVENUS ANALYSIS

12.12.3 PRODUCT PORTFOLIO

12.12.4 RECENT DEVELOPMENT

12.13 OLIN CORPORATION

12.13.1 COMPANY SNAPSHOT

12.13.2 REVENUE ANALYSIS

12.13.3 PRODUCT PORTFOLIO

12.13.4 RECENT DEVELOPMENT

12.14 SK GEO CENTRIC CO., LTD. (A SUBSIDIARY OF SK NORTH AMERICA CHEMICAL)

12.14.1 COMPANY SNAPSHOT

12.14.2 PRODUCT PORTFOLIO

13 QUESTIONNAIRE

14 RELATED REPORTS

表格列表

TABLE 1 INNOVATORS OF GENERIC DRUGS

TABLE 2 DRUGS DEVELOPMENT IN THE YEAR 2021

TABLE 3 CLASSES OF SOLVENTS AND THEIR HARMFUL EFFECTS

TABLE 4 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 5 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 6 NORTH AMERICA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 7 NORTH AMERICA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)

TABLE 8 NORTH AMERICA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 9 NORTH AMERICA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 10 NORTH AMERICA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 11 NORTH AMERICA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)

TABLE 12 NORTH AMERICA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 13 NORTH AMERICA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 14 NORTH AMERICA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 15 NORTH AMERICA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)

TABLE 16 NORTH AMERICA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 17 NORTH AMERICA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 18 NORTH AMERICA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 19 NORTH AMERICA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS )

TABLE 20 NORTH AMERICA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 21 NORTH AMERICA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 22 NORTH AMERICA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 23 NORTH AMERICA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)

TABLE 24 NORTH AMERICA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 25 NORTH AMERICA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 26 NORTH AMERICA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 27 NORTH AMERICA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)

TABLE 28 NORTH AMERICA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 29 NORTH AMERICA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 30 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 31 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)

TABLE 32 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 33 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 34 NORTH AMERICA OTHERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 35 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)

TABLE 36 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)

TABLE 37 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)

TABLE 38 NORTH AMERICA PHARMACEUTICAL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 39 NORTH AMERICA PHARMACEUTICAL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)

TABLE 40 NORTH AMERICA RESEARCH LABORATORIES IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 41 NORTH AMERICA RESEARCH LABORATORIES IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)

TABLE 42 NORTH AMERICA CHEMICAL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 43 NORTH AMERICA CHEMICAL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)

TABLE 44 NORTH AMERICA OTHERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 45 NORTH AMERICA OTHERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)

TABLE 46 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY COUNTRY, 2019-2028 (USD THOUSAND)

TABLE 47 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY COUNTRY, 2019-2028 (THOUSAND TONS)

TABLE 48 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 49 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 50 NORTH AMERICA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 51 NORTH AMERICA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 52 NORTH AMERICA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 53 NORTH AMERICA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 54 NORTH AMERICA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 55 NORTH AMERICA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 56 NORTH AMERICA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 57 NORTH AMERICA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 58 NORTH AMERICA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 59 NORTH AMERICA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 60 NORTH AMERICA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 61 NORTH AMERICA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 62 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 63 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 64 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)

TABLE 65 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)

TABLE 66 U.S. PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 67 U.S. PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 68 U.S. ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 69 U.S. ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 70 U.S. AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 71 U.S. AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 72 U.S. KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 73 U.S. KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 74 U.S. ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 75 U.S. ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 76 U.S. AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 77 U.S. AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 78 U.S. ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 79 U.S. ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 80 U.S. CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 81 U.S. CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 82 U.S. PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)

TABLE 83 U.S. PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)

TABLE 84 CANADA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 85 CANADA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 86 CANADA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 87 CANADA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 88 CANADA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 89 CANADA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 90 CANADA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 91 CANADA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 92 CANADA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 93 CANADA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 94 CANADA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 95 CANADA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 96 CANADA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 97 CANADA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 98 CANADA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 99 CANADA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 100 CANADA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)

TABLE 101 CANADA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)

TABLE 102 MEXICO PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 103 MEXICO PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 104 MEXICO ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 105 MEXICO ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 106 MEXICO AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 107 MEXICO AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 108 MEXICO KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 109 MEXICO KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 110 MEXICO ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 111 MEXICO ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 112 MEXICO AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 113 MEXICO AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 114 MEXICO ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 115 MEXICO ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 116 MEXICO CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 117 MEXICO CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)

TABLE 118 MEXICO PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)

TABLE 119 MEXICO PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)

图片列表

FIGURE 1 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: PRODUCT LIFELINE CURVE

FIGURE 7 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: MULTIVARIATE MODELLING

FIGURE 8 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 9 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: DBMR POSITION GRID

FIGURE 10 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 12 NORTH AMERICA PHARMACEUTICAL SOLVENT: THE MARKET CHALLENGE MATRIX

FIGURE 13 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: SEGMENTATION

FIGURE 14 ASIA-PACIFIC REGION IS EXPECTED TO DOMINATE THE NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, AND TO GROW WITH THE HIGHEST CAGR FROM 2021 TO 2028

FIGURE 15 THE GROWING PHARMACEUTICAL AND HEALTHCARE SECTOR ACROSS THE GLOBE IS DRIVING THE GROWTH OF THE NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 16 ALCOHOL SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET IN 2021 & 2028

FIGURE 17 VALUE CHAIN OF PHARMACEUTICAL SOLVENT

FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET

FIGURE 19 WORLDWIDE GDP PER CAPITA INCOME

FIGURE 20 NEW DRUGS APPROVED BY THE U.S. FOOD AND DRUG ADMINISTRATION (2010-2020)

FIGURE 21 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: BY PRODUCT, 2020

FIGURE 22 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: BY APPLICATION, 2020

FIGURE 23 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: SNAPSHOT (2020)

FIGURE 24 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: BY COUNTRY (2020)

FIGURE 25 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: BY COUNTRY (2021 & 2028)

FIGURE 26 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 27 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: BY PRODUCT (2021-2028)

FIGURE 28 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: COMPANY SHARE 2020 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.